Methylprednisolone, intravenous immunoglobulin, tocilizimab or anakinra for children with Paediatric Inflammatory Multisystem Syndrome temporally associated with SARS CoV-2 (PIMS-TS, MIS-C) – report from a randomised, controlled, open-label, platform trial
LANDRAY M., HAYNES R., STAPLIN N., SPATA E., PETO L., KNIGHT M., MAFHAM M., EMBERSON J., HORBY P.